CDMO - Avid Bioservices Inc Stock Price, Fair Value and News

$12.30-0.03 (-0.24%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CDMO Price Action

Last 7 days

-0.3%

Last 30 days

0.7%

Last 90 days

6.0%

Trailing 12 Months

91.9%

CDMO RSI Chart

CDMO Valuation

Market Cap

786.7M

Price/Earnings (Trailing)

-5.17

Price/Sales (Trailing)

5.23

EV/EBITDA

-52.6

Price/Free Cashflow

-81.27

CDMO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CDMO Fundamentals

CDMO Revenue

Revenue (TTM)

150.4M

Rev. Growth (Yr)

31.84%

Rev. Growth (Qtr)

-16.66%

CDMO Earnings

Earnings (TTM)

-152.1M

Earnings Growth (Yr)

-82.82%

Earnings Growth (Qtr)

-214.53%

CDMO Profitability

Operating Margin

63.22%

EBT Margin

-23.42%

Return on Equity

-339.34%

Return on Assets

-47%

Free Cashflow Yield

-1.23%

CDMO Investor Care

Shares Dilution (1Y)

1.14%

Diluted EPS (TTM)

-2.4

CDMO Alerts

Point72 Asset Management, L.P. reported owning 6.7% of CDMO [2024-11-14]
Big jump in Revenue (Y/Y)
Big fall in earnings (Y/Y)
Losses in recent quarter

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	136.7M	139.9M	142.4M	150.4M
2023	140.7M	149.3M	150.3M	140.9M
2022	116.0M	119.6M	125.5M	134.2M
2021	80.8M	95.9M	101.2M	106.3M
2020	64.2M	59.7M	69.8M	72.6M
2019	43.5M	53.6M	56.3M	64.4M
2018	64.6M	53.6M	39.1M	36.5M
2017	58.5M	57.6M	79.1M	68.5M
2016	35.2M	44.7M	40.6M	54.5M
2015	23.9M	26.8M	31.0M	34.2M
2014	20.2M	22.4M	23.2M	22.2M
2013	19.5M	21.7M	22.1M	23.3M
2012	15.9M	15.2M	13.8M	15.7M
2011	17.1M	13.5M	15.9M	15.5M
2010	0	27.9M	24.3M	20.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About Avid Bioservices Inc

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

CEO	Mr. Nicholas Stewart Green B.Sc., MBA
WEBSITE	avidbio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	365

Avid Bioservices Inc Frequently Asked Questions

What is the ticker symbol for Avid Bioservices Inc? What does CDMO stand for in stocks?

CDMO is the stock ticker symbol of Avid Bioservices Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Avid Bioservices Inc (CDMO)?

As of Fri Dec 20 2024, market cap of Avid Bioservices Inc is 786.75 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CDMO stock?

You can check CDMO's fair value in chart for subscribers.

Is Avid Bioservices Inc a good stock to buy?

The fair value guage provides a quick view whether CDMO is over valued or under valued. Whether Avid Bioservices Inc is cheap or expensive depends on the assumptions which impact Avid Bioservices Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CDMO.

What is Avid Bioservices Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, CDMO's PE ratio (Price to Earnings) is -5.17 and Price to Sales (PS) ratio is 5.23. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CDMO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Avid Bioservices Inc's stock?

In the past 10 years, Avid Bioservices Inc has provided 0.024 (multiply by 100 for percentage) rate of return.